A drug shown to reduce risk of prostate cancer by more than a third has no impact on lifespan but further reduces the risk of prostate cancer, according to a long-term follow-up to a groundbreaking study led by the director of the Cancer Therapy (and) Research Center. Reducing the risk of prostate tumors by about 30 percent - and low-grade tumors by 43 percent - means thousands of men can avoid a cancer diagnosis and subsequent treatments that significantly affect ...Saturday 17 August 2013
Finasteride Saves Men from Prostate Cancer, Doesn't Increase Risk of Death: Study
A drug shown to reduce risk of prostate cancer by more than a third has no impact on lifespan but further reduces the risk of prostate cancer, according to a long-term follow-up to a groundbreaking study led by the director of the Cancer Therapy (and) Research Center. Reducing the risk of prostate tumors by about 30 percent - and low-grade tumors by 43 percent - means thousands of men can avoid a cancer diagnosis and subsequent treatments that significantly affect ...
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment